Concepedia

Benjamin Andrick

BA

3

Publications

79

Citations

3

H-Index

2018

Active since

Affiliations

Florida College(Current)

Benjamin Andrick is an author at Florida College specializing in oncology, cancer therapeutics, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2018–2022

3

Publications

3

Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial

Amber B. Clemmons, Julianne Orr, Benjamin Andrick et al. · Biology of Blood and Marrow Transplantation · 2018 · 54 citations · Full text

, , +13

Impact of a pharmacist-led telehealth oral chemotherapy clinic

A. Mathur, Tristan Maiers, Benjamin Andrick · American Journal of Health-System Pharmacy · 2022 · 13 citations

Gilteritinib: A Novel FLT3 Inhibitor for Relapsed/Refractory Acute Myeloid Leukemia

Dennis Marjoncu, Benjamin Andrick · Journal of the Advanced Practitioner in Oncology · 2020 · 12 citations · Full text

Rows per page

1–3 of 3